Plain-English translation of NCT06855901 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new wearable brain-monitoring device—small sensors placed under your skin—to better track seizures in people with hard-to-treat or rare epilepsies. Instead of spending time in a hospital for monitoring, you would wear these sensors at home for several months. The goal is to give your doctors much better information about how often you're having seizures and how your treatment is working.
Many people with severe epilepsies have seizures that are difficult to control with medication, and doctors struggle to know exactly how often these seizures occur—especially when patients are at home or living in care facilities. This trial exists to see whether continuous home monitoring with wearable sensors can provide the clear, detailed information doctors need to adjust treatment and improve daily life.
You likely qualify if…
You likely don't qualify if…
First, a surgeon will perform a brief procedure to implant small electrodes under your skin, positioned over the part of your brain where your seizures start. Then you'll go home and wear the wearable monitoring system continuously for at least 12 weeks (up to 24 weeks). During this time, the device will record your brain activity and seizure patterns while you go about your daily life, and your doctor will be able to review this information to adjust your treatment as needed.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy